Global Benefit of SGLT2 Inhibitors in Heart Failure With Reduced Ejection Fraction

JACC Asia. 2022 Apr 19;2(2):154-156. doi: 10.1016/j.jacasi.2022.03.002. eCollection 2022 Apr.

Authors

Nicholas K Brownell¹, Boback Ziaeian¹, Gregg C Fonarow²

Affiliations

¹ Division of Cardiology, University of California, Los Angeles (UCLA), Los Angeles, California, USA.
² Ahmanson-UCLA Cardiomyopathy Center, Ronald Reagan-UCLA Medical Center, Los Angeles, California, USA.

No abstract available

Keywords: Asia; SGLT2 inhibitor; ejection fraction; heart failure.

Publication types

Editorial